Group items tagged

We are a special inclusive school for children on the autism spectrum and typical siblings.

The type of mercury used in thimerosal is generally cleared from the body within six weeks, which in theory would render it harmless. But according to those researchers who believe that the preservative causes autism, babies born during that 20-year window were injected with many times the "safe" level as determined by the FDA -- and some, they feel, were genetically incapable of clearing the doses of mercury from their bodies. Mercury is, in fact, a neurotoxin, and the theory is that the recent leap in autism diagnoses can be directly tied to thimerosal.

In 2004, the Institute of Medicine undertook a comprehensive review of all the published literature on thimerosal and autism and concluded that the available evidence demonstrate that there was no link. The CDC launched a series of studies that examined the relationship between the incidence of autism and the amount of mercury a child received in the first 6 months of life and also found no relationship. Although all published credible studies have found no link between thimerosal and autism, some continue to be unconvinced.

At present, the thimerosal controversy continues, even though the removal of thimerosal from vaccines has not resulted in lower rates of autism diagnoses.

Developmental abnormalities in the mirror neuron system may contribute to social deficits in autism.

Now, a new study published in Biological Psychiatry reports that the mirror system in individuals with autism is not actually broken, but simply delayed.

While most of us have their strongest mirror activity while they are young, autistic individuals seem to have a weak mirror system in their youth, but their mirror activity increases with age, is normal by about age 30 and unusually high thereafter.

The study, published online today in the journal Pediatrics, examined an intervention called the Early Start Denver Model, which combines applied behavioral analysis (ABA) teaching methods with developmental 'relationship-based' approaches.

The five-year study took place at the University of Washington (UW) in Seattle and was led by Dawson, then a professor of psychology and director of the university's Autism Center, in partnership with Rogers. It involved therapy for 48 diverse, 18- to 30-month-old children with autism and no other health problems.

At the conclusion of the study, the IQs of the children in the intervention group had improved by an average of approximately 18 points, compared to a little more than four points in the comparison group. The intervention group also had a nearly 18-point improvement in receptive language (listening and understanding) compared to approximately 10 points in the comparison group. Seven of the children in the intervention group had enough improvement in overall skills to warrant a change in diagnosis from autism to the milder condition known as 'pervasive developmental disorder not otherwise specified,' or PDD-NOS. Only one child in the community-based intervention group had an improved diagnosis.

Advanced maternal age is linked to a significantly elevated risk of having a child with autism, regardless of the father's age, according to an exhaustive study of all births in California during the 1990s by UC Davis Health System researchers.

The researchers note that understanding the relationship between increased parental age and autism risk is critical to understanding its biological causes. Earlier studies have observed that advanced maternal age is a risk factor for a variety of other birth-related conditions, including infertility, early fetal loss, low birth-weight, chromosomal aberrations and congenital anomalies.

One possible clue comes from a 2008 UC Davis study that found some mothers of children with autism had antibodies to fetal brain protein, while none of the mothers of typical children did. Advancing age has been associated with an increase in autoantibody production.